Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2023 Earnings Call Transcript

Unidentified Analyst: Great. And also for ZYNRELEF, also curious, have you seen or had different physician feedback on ZYNRELEF in terms of different kinds of surgical indications? And also understanding the VAN could be available by mid-2024. How quickly do you think we can see the change on sales growth trajectory after the VAN launch? And what kind of efforts are you making between now and VAN launch for sales improvement? Thank you.

Craig Collard: Yes. Well, I think the good news is the VAN is on track from a timeline perspective. We do believe we’ll have that out in midyear of next year. And it does two things. One, it helps with the sterility issue, it makes that [indiscernible]. And two, it’s going to change the time to pull the product. So instead of three to four minutes, it could be upwards of 20 to 30 seconds. And so I think it’s dramatically going to impact the product from a standpoint of just ease of use. Again, our — I mentioned before about looking to possibly partner with a surgical partner in the surgical suite. I think that’s something as well as we lead into the VAN and with an expanded label and hopefully expanded footprint. All of those things should lead to higher sales and higher sales growth But again, I want to reiterate, we have not forecasted that as far as getting us to profitability.

These would be additional sales. So, we feel pretty comfortable with that. And again, everything seems to be on track from a timeline perspective.

Unidentified Analyst: Okay. Very helpful. Thank you.

Craig Collard: Thank you.

Operator: We have no further questions in the queue at this time. Craig, I’ll turn it back to you for closing remarks.

Craig Collard: I just want to thank everyone again. This is our second earnings call, but we really do appreciate the time and patience. I think the business is making some strides in transforming. It’s going to take a little bit of time, but we’re getting there. And I think we’ve had some significant things that have happened this quarter. So, we look forward to updating everyone next quarter. Thank you.

Operator: Ladies and gentlemen, this concludes today’s conference call. Thank you for your participation, and you may now disconnect. Goodbye.